The Drug Industry: GlaxoSmithKline, Merck and Novartis Again Rank Highest on Access to Poor
Antibotics in Animals Need Limits, F.D.A. Says
Half of Breast Cancer Patients Stop Taking Hormone Drugs Early
Latest Study on Diabetes Drug Avandia Finds No Heart Risks